The Scientist

» molecular biology and disease/medicine

Most Recent

image: Hurry Up, FDA

Hurry Up, FDA

By | December 6, 2012

The US Food and Drug Administration is taking steps to get new devices on the market sooner—and antibiotics may be next.

0 Comments

image: MicroRNAs Repair Heart Cells

MicroRNAs Repair Heart Cells

By | December 5, 2012

The US Food and Drug Administration is taking steps to get new devices on the market sooner—and antibiotics may be next.

1 Comment

image: New Mental Health Manual

New Mental Health Manual

By | December 5, 2012

The US Food and Drug Administration is taking steps to get new devices on the market sooner—and antibiotics may be next.

1 Comment

image: Special Review for H5N1 Grants?

Special Review for H5N1 Grants?

By | December 4, 2012

The US Food and Drug Administration is taking steps to get new devices on the market sooner—and antibiotics may be next.

0 Comments

image: Stem Cells from Blood

Stem Cells from Blood

By | December 3, 2012

The US Food and Drug Administration is taking steps to get new devices on the market sooner—and antibiotics may be next.

0 Comments

image: An Epi Phenomenon

An Epi Phenomenon

By | December 1, 2012

The US Food and Drug Administration is taking steps to get new devices on the market sooner—and antibiotics may be next.

5 Comments

image: Contributors

Contributors

By | December 1, 2012

The US Food and Drug Administration is taking steps to get new devices on the market sooner—and antibiotics may be next.

0 Comments

image: In the Long Run

In the Long Run

By | December 1, 2012

The US Food and Drug Administration is taking steps to get new devices on the market sooner—and antibiotics may be next.

1 Comment

image: Waking Cancer Cells

Waking Cancer Cells

By | December 1, 2012

The US Food and Drug Administration is taking steps to get new devices on the market sooner—and antibiotics may be next.

0 Comments

image: Virus Monopolizes Host’s Repairmen

Virus Monopolizes Host’s Repairmen

By | November 29, 2012

The US Food and Drug Administration is taking steps to get new devices on the market sooner—and antibiotics may be next.

3 Comments

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech